DiaMedica Therapeutics (DMAC) Gains from Sales and Divestitures (2023 - 2025)
DiaMedica Therapeutics (DMAC) reported Gains from Sales and Divestitures of $174515.0 for Q4 2025, down 38.74% on a YoY basis from $284886.0 in Q4 2024, and down 38.74% quarter-over-quarter from $284886.0 in Q4 2024.
DiaMedica Therapeutics (DMAC) Gains from Sales and Divestitures (2023 - 2025) Analysis & Trends
DiaMedica Therapeutics has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $174515.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 38.74% year-over-year to $174515.0; the trailing twelve-month figure through Dec 2025 stood at $174515.0 (down 38.74% YoY), and the FY2025 full-year result was $174515.0, down 38.74% from the prior year.
- Gains from Sales and Divestitures for Q4 2025 stood at $174515.0, down from $284886.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $284886.0 in Q4 2024, with the low at $174515.0 in Q4 2025.
- Historically, Gains from Sales and Divestitures has averaged $224467.0 across 3 years, with a median of $214000.0 in 2023.
- Annual changes were most pronounced in 2024 — Gains from Sales and Divestitures surged 33.12% — and 2025, when it slumped 38.74%.
- DiaMedica Therapeutics' Gains from Sales and Divestitures stood at $214000.0 in 2023, then surged by 33.12% to $284886.0 in 2024, then tumbled by 38.74% to $174515.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $174515.0 (Q4 2025), $284886.0 (Q4 2024), and $214000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 174,515.00 |
| Dec 31, 2025 | 174,515.00 |
| Dec 31, 2024 | 284,886.00 |
| Dec 31, 2024 | 284,886.00 |
| Dec 31, 2023 | 214,000.00 |
| Dec 31, 2023 | 214,000.00 |